<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Adverse Effects of Amiodarone

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 1998 United States English Publisher:WileyJournal:Pacing and Clinical Electrophysiology, volume 21, pages 108-120 (issn: 0147-8389, eissn: 1540-8159,

Authors: JAFARI‐FESHARAKI, MAHTAB; SCHEINMAN, MELVIN M;

doi: 10.1111/j.1540-8159.1998.tb01068.x

pmid: 9474655

Adverse Effects of Amiodarone

- Summary
- Subjects
- Metrics

Abstract

Amiodarone was introduced 30 years ago as an antianginal agent and subsequently has been used as an antiarrhythmic agent. This drug was initially used for patients with malignant ventricular arrhythmias; however, currently it is being used broadly for rate and rhythm control in patients with atrial fibrillation. At first, amiodarone was primarily used by cardiologists and today it is used throughout the medical profession. Amiodarone therapy can potentially result in a wide range of adverse effects. The majority of these adverse effects are dose related and reversible. The following is a review of the adverse effects and drug interactions of amiodarone along with recommendations for identification and management of these adverse effects.

Country

United States

Related Organizations

University of California, San Francisco
United States
University of California System
United States
Western University of Health Sciences
United States

Keywords

Infusions, Clinical Sciences, Biomedical Engineering, Amiodarone, Clinical sciences, Cardiovascular, Cardiovascular medicine and haematology, Humans, Drug Interactions, Infusions, Intravenous, amiodarone, Biomedical and Clinical Sciences, Evaluation of treatments and therapeutic interventions, Pharmacology and Pharmaceutical Sciences, digoxin, drug interactions, warfarin, Cardiovascular System & Hematology, 5.1 Pharmaceuticals, 6.1 Pharmaceuticals, adverse effects, Patient Safety, Development of treatments and therapeutic interventions, antiarrhythmics, Intravenous, Anti-Arrhythmia Agents

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	82
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%